
Natarajan Panneerselvam
About Natarajan Panneerselvam
Data last updated:
Natarajan Panneerselvam is a Director at Spinach Pharma Private Limited (since 2014). The company operates in Pharma. Spinach Pharma Private Limited reported revenue of ₹1.23 Cr (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Sep 2014 | 2013 | ₹1.23 Cr (FY 2023) | Active |
Board colleagues of Natarajan Panneerselvam
| Name | DIN | Company | Designation |
|---|---|---|---|
| Cheyyanur Venugopalapillai Kesavamurthy | 06662966 | Spinach Pharma Private Limited | Director |
| Ettya Gounder Venkatesan | 06662920 | Spinach Pharma Private Limited | Director |
| Kalipillai Mahalingam Shanmugam | 06961338 | Spinach Pharma Private Limited | Director |
| Kesava Murthy Malarselvi | 11361937 | Spinach Pharma Private Limited | Additional Director |
| Panneerselvam Suguna | 11374295 | Spinach Pharma Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Natarajan Panneerselvam
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Natarajan Panneerselvam
Natarajan Panneerselvam currently holds 1 directorship: Spinach Pharma Private Limited (Director, since 01 Sep 2014, revenue ₹1.23 Cr (FY 2023)).
Natarajan Panneerselvam was first appointed on 01 Sep 2014 as Director at Spinach Pharma Private Limited.
The current boards of Natarajan Panneerselvam's companies include Cheyyanur Venugopalapillai Kesavamurthy (Spinach Pharma Private Limited), Ettya Gounder Venkatesan (Spinach Pharma Private Limited), Kalipillai Mahalingam Shanmugam (Spinach Pharma Private Limited), Kesava Murthy Malarselvi (Spinach Pharma Private Limited), Panneerselvam Suguna (Spinach Pharma Private Limited).